We are live on ! Find out more
EPL

EDBI Pte Ltd Portfolio holdings

AUM $94.4M
1-Year Est. Return 32.71%
This Fund
S&P 500
This Quarter Est. Return
-29.96%
1 Year Est. Return
+32.71%
3 Year Est. Return
+6.21%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$42.3M
Cap. Flow
+$4.93M
Cap. Flow %
4.57%
Top 10 Hldgs %
90.38%
Holding
25
New
3
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$4.18M
2
DASH icon
DoorDash
DASH
+$453K
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$262K
4
LOGC
ContextLogic
LOGC
+$30.9K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 54.78%
2 Industrials 24.58%
3 Healthcare 19.96%
4 Consumer Discretionary 0.36%
5 Financials 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JOBY icon
1
Joby Aviation
JOBY
$7.07B
$21.9M 20.3%
4,459,563
– –
RGTI icon
2
Rigetti Computing
RGTI
$5.49B
$15.9M 14.76%
4,339,408
– –
CXM icon
3
Sprinklr
CXM
$1.86B
$11.2M 10.41%
1,110,777
– –
SNOW icon
4
Snowflake
SNOW
$114B
$11.2M 10.34%
80,221
+26,414
+49% +$4.18M
FMTX
5
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$8.74M 8.1%
1,268,805
– –
WKME
6
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$7.72M 7.16%
761,864
– –
GRAB icon
7
Grab
GRAB
$14.7B
$7.14M 6.62%
2,822,035
– –
ERAS icon
8
Erasca
ERAS
$6.82B
$4.95M 4.59%
888,888
– –
PL icon
9
Planet Labs
PL
$7.54B
$4.61M 4.28%
1,065,593
– –
NUVB icon
10
Nuvation Bio
NUVB
$2.45B
$4.12M 3.82%
1,270,504
– –
AVPT icon
11
AvePoint
AVPT
$3.03B
$3.04M 2.82%
700,000
– –
NBP
12
NovaBridge Biosciences American Depositary Shares
NBP
$219M
$2.51M 2.33%
222,136
– –
MQ icon
13
Marqeta
MQ
$1.69B
$2.07M 1.92%
63,938
– –
PEAR
14
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$658K 0.61%
427,070
– –
DDOG icon
15
Datadog
DDOG
$87.2B
$584K 0.54%
6,136
– –
DASH icon
16
DoorDash
DASH
$100B
$366K 0.34%
+5,701
New +$453K
HOOD icon
17
Robinhood
HOOD
$98.7B
$342K 0.32%
41,638
– –
KROS icon
18
Keros Therapeutics
KROS
$223M
$279K 0.26%
10,105
– –
HCP
19
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$191K 0.18%
+6,500
New +$262K
RLAY icon
20
Relay Therapeutics
RLAY
$4.26B
$125K 0.12%
7,484
– –
NRIX icon
21
Nurix Therapeutics
NRIX
$2.79B
$94K 0.09%
7,442
– –
ALXO icon
22
ALX Oncology
ALXO
$283M
$45K 0.04%
5,613
– –
BILL icon
23
BILL Holdings
BILL
$4.87B
$33K 0.03%
296
– –
LOGC
24
DELISTED
ContextLogic
LOGC
$27K 0.03%
+571
New +$30.9K
OLMA icon
25
Olema Pharmaceuticals
OLMA
$944M
$13K 0.01%
3,181
– –

Similar funds

TB
Treynor Bancshares Treynor, Iowa $94.7M AUM 8.69% 1-Year Est. Return
GIM
Genesis Investment Management London, United Kingdom $91.1M AUM 1.26% 1-Year Est. Return
MFIMFI
Mesirow Financial Investment Management - Fixed Income Chicago, Illinois $98.4M AUM 13.93% 1-Year Est. Return
ACM
Agincourt Capital Management Richmond, Virginia $99.9M AUM 7.36% 1-Year Est. Return
SW
Signify Wealth Saint Louis, Missouri $88.6M AUM 32.1% 1-Year Est. Return
RCM
Riggs Capital Management American Fork, Utah $102M AUM
TKP
Tallon Kerry Patrick $104M AUM
WWS
Wellington Wealth Strategies Indianapolis, Indiana $110M AUM 17.07% 1-Year Est. Return

EDBI Pte Ltd's Q2 2022 Portfolio in Review

As of Q2 2022, EDBI Pte Ltd held 25 positions worth $108M, down 28% from $150M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

EDBI Pte Ltd deployed $4.93M of net new capital in Q2 2022, opening 3 new positions and adding to 1 existing holding. Its largest new stake was DoorDash: 5,701 shares worth $366K.

By sector, the portfolio is most concentrated in Technology at 55% of assets, up from 54% a quarter earlier, followed by Industrials and Healthcare.

  • EDBI Pte Ltd's largest Q2 2022 buy was DoorDash: 5,701 shares worth $366K.
  • EDBI Pte Ltd added most to Snowflake in Q2 2022, an estimated $4.18M increase.
  • EDBI Pte Ltd's ten largest holdings make up 90% of its $108M portfolio in Q2 2022.
  • EDBI Pte Ltd opened 3 new positions and closed 0 in Q2 2022.
  • EDBI Pte Ltd's portfolio value fell 28% quarter-over-quarter to $108M.

Based on EDBI Pte Ltd's 13F filing for Q2 2022, filed 11 Aug 2022.